PHAT EBITDA Margin
Phathom Pharmaceuticals Inc · EBITDA Margin
PHAT EBITDA Margin
Latest reported-3.18%period ending
PHAT Quarterly EBITDA Margin (0.00% → -3.18%)
Quarterly ebitda margin
High-resolution chart · PNG
PHAT ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -3.1842% | |
| -24.8057% | |
| -7.9901% | |
| -27.6927% | |
| -147.1281% | |
| -266.7274% | |
| -187.6517% | |
| -409.1365% | |
| -1,003.3452% | |
| -3,424.1632% | |
| -9,729.6188% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |